Conservation of critical functional domains in murine plasminogen activator inhibitor-1.
D000818:Animals; D015153:Blotting, Western; D017124:Conserved Sequence; D004305:Dose-Response Relationship, Drug; D004591:Electrophoresis, Polyacrylamide Gel; D004797:Enzyme-Linked Immunosorbent Assay; D004926:Escherichia coli / Q000378:metabolism; D005822:Genetic Vectors; D006801:Humans; D007700:Kinetics; D026503:Low Density Lipoprotein Receptor-Related Protein-1 / Q000378:metabolism; D051379:Mice; D008822:Mice, Transgenic; D016297:Mutagenesis, Site-Directed; D017395:Plasminogen Activator Inhibitor 1 / Q000737:chemistry*; D011485:Protein Binding; D017434:Protein Structure, Tertiary; D011994:Recombinant Proteins / Q000737:chemistry; D013329:Structure-Activity Relationship; D020349:Surface Plasmon Resonance; D013696:Temperature; D013997:Time Factors; D014018:Tissue Distribution; D010959:Tissue Plasminogen Activator / Q000378:metabolism; D019096:Vitronectin / Q000378:metabolism
D026503:Low Density Lipoprotein Receptor-Related Protein-1; D017395:Plasminogen Activator Inhibitor 1; D011994:Recombinant Proteins; D019096:Vitronectin; D010959:Tissue Plasminogen Activator